SOPH
Sophia Genetics·NASDAQ
--
--(--)
--
--(--)
3.69 / 10
Netural
Capital flows show a mixed but slightly positive bias: small, medium, and large inflows are trending upward, although overall and extra-large patterns are negative. Analyst sentiment is overwhelmingly bullish with a unanimous Strong Buy rating from Guggenheim, yet the historical win rate is low, indicating that the positive flow and analyst views may not fully offset the weak technical backdrop.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-26
InstitutionGuggenheim
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for SOPH?
- SOPH holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.69/10 (Netural).
